Abstract: A Meissner-Effect Transition-Edge-Sensor (ME-TES) microcalorimeter device may have one or more microcalorimeter elements, each including an absorber body composed of a superconductive element that is arranged to absorb incoming photons or radiative particles. A planar pickup coil substantially surrounds the absorber body and is located within a magnetic sensing distance of the absorber body. Absorption of incoming photons or radiative particles increases the temperature of the superconductive element, resulting in a change in magnetic flux through the superconductive element. This change in magnetic flux induces a transient electric current in the planar pickup coil that may be sensed using a readout circuit. A method is provided for fabricating an ME-TES microcalorimeter device.

Abstract: A method is provided for making gratings of gold or other metal in silicon substrates. The disclosed method may achieve high aspect ratios. According to the disclosed method, a silicon wafer is through-etched. A seed layer of metal is vapor-deposited on one side of the wafer, and a layer of metal is electrodeposited on the seed layer. The electrodeposited metal plugs the trenches and provides a conductive surface for subsequent electrodeposition. The trenches are then filled by electrodeposition from within the trenches, so that the walls of the metal grating grow on the metal plugs.

Abstract: The present invention relates to a method of fabricating an electrode array, in which an underlying handle wafer is removed to provide a planar device having the electrode array. Also provided are wafers including a plurality of planar devices having an electrode array, as well as sensors including such an electrode array.

Abstract: The various technologies presented herein relate to formation of carbon micromechanical systems (CMEMS), wherein the CMEMS comprise multiple layers of carbon structures and are formed using a plurality of photoresist precursors that are processed to form carbon. The various embodiments can be utilized in producing a plurality of CMEMS with full production level fabrication, e.g., 6 inch wafers can be processed. A pyrolyzed layer of carbon is lithographically defined after pyrolysis, wherein the post-pyrolysis etch process can produce carbon structures having repeatable and accurate device geometries, with straight sidewalls. A sacrificial layer can be applied to facilitate separation of a first carbon layer from a second carbon layer, wherein, upon pyrolysis to form the second carbon layer and lithography thereof, the sacrificial layer is removed to form a CMEMS comprising a first carbon layer (e.g., comprising bottom contacts) located beneath a second carbon layer (e.g., a mechanical layer).

Abstract: A patient monitoring system for audiovisual observation and communication between a remote patient observation station and a patient hospital room to provide continuous monitoring of patient condition and status. Embodiments of the system include a management server to provide centralized operation and administration of one or more media servers. Each media server provides centralized operation and administration of one or more monitoring devices, which may include platforms such as mobile wheeled carts, mobile wall units, and fixed cameras and intercoms.

Abstract: Wafer scale oblique angle etching of a semiconductor substrate is performed in a conventional plasma etch chamber by using a fixture that supports a multiple number of separate Faraday cages. Each cage is formed to include an angled grid surface and is positioned such that it will be positioned over a separate one of the die locations on the wafer surface when the fixture is placed over the wafer. The presence of the Faraday cages influences the local electric field surrounding each wafer die, re-shaping the local field to be disposed in alignment with the angled grid surface. The re-shaped plasma causes the reactive ions to follow a linear trajectory through the plasma sheath and angled grid surface, ultimately impinging the wafer surface at an angle. The selected geometry of the Faraday cage angled grid surface thus determines the angle at with the reactive ions will impinge the wafer.

Abstract: A microporous carbon scaffold is produced by lithographically patterning a carbon-containing photoresist, followed by pyrolysis of the developed resist structure. Prior to exposure, the photoresist is loaded with a nanoparticulate material. After pyrolysis, the nanonparticulate material is dispersed in, and intimately mixed with, the carbonaceous material of the scaffold, thereby yielding a carbon composite structure.

Abstract: A medical treatment device (200), for treating reflux from a stomach (201) to an oesophagus (202) and for delivering a therapeutic agent to an inner surface of the oesophagus (202), comprises a valve member (203), a lining member (204), and a support member (205). The valve member (203) is movable between a closed configuration and an open configuration, in which the valve member (203) facilitates passage of material between the oesophagus (202) and the stomach (201). The valve member (203) is biased towards the closed configuration and gradually moves over a period of 4 to 10 secs from the open configuration to the closed configuration. The support member (205) supports the device (200) relative to the oesophagus (202) and the stomach (201). The lining member (204) lines part of the inner surface of the oesophagus (202) for delivery of a therapeutic agent to the oesophagus (202).

Abstract: A medical treatment device (200), for treating reflux from a stomach (201) to an esophagus (202) and for delivering a therapeutic agent to an inner surface of the esophagus (202), comprises a valve member (203), a lining member (204), and a support member (205). The valve member (203) is movable between a closed configuration and an open configuration, in which the valve member (203) facilitates passage of material between the esophagus (202) and the stomach (201). The valve member (203) is biased towards the closed configuration and gradually moves over a period of 4 to 10 secs from the open configuration to the closed configuration. The support member (205) supports the device (200) relative to the esophagus (202) and the stomach (201). The lining member (204) lines part of the inner surface of the esophagus (202) for delivery of a therapeutic agent to the esophagus (202).

Abstract: A medical treatment device (200), for treating reflux from a stomach (201) to an esophagus (202) and for delivering a therapeutic agent to an inner surface of the esophagus (202), comprises a valve member (203), a lining member (204), and a support member (205). The valve member (203) is movable between a closed configuration and an open configuration, in which the valve member (203) facilitates passage of material between the esophagus (202) and the stomach (201). The valve member (203) is biased towards the closed configuration and gradually moves over a period of 4 to 10 secs from the open configuration to the closed configuration. The support member (205) supports the device (200) relative to the esophagus (202) and the stomach (201). The lining member (204) lines part of the inner surface of the esophagus (202) for delivery of a therapeutic agent to the esophagus (202).

Abstract: A medical treatment device (200), for treating reflux from a stomach (201) to an oesophague (202) and for delivering a therapeutic agent to an inner surface of the oesophague (202), comprises a valve member (203), a lining member (204), and a support member (205). The valve member (203) is movable between a closed configuration and an open configuration, in which the valve member (203) facilitates passage of material between the oesophague (202) and the stomach (201). The valve member (203) is biased towards the closed configuration and gradually moves over a period of 4 to 10 secs from the open configuration to the closed configuration. The support member (205) supports the device (200) relative to the oesophague (202) and the stomach (201). The lining member (204) lines part of the inner surface of the oesophague (202) for delivery of a therapeutic agent to the oesophague (202).

Abstract: A medical treatment device (200), for treating reflux from a stomach (201) to an oesophagus (202) and for delivering a therapeutic agent to an inner surface of the oesophagus (202), comprises a valve member (203), a lining member (204), and a support member (205). The valve member (203) is movable between a closed configuration and an open configuration, in which the valve member (203) facilitates passage of material between the oesophagus (202) and the stomach (201). The valve member (203) is biased towards the closed configuration and gradually moves over a period of 4 to 10 secs from the open configuration to the closed configuration. The support member (205) supports the device (200) relative to the oesophagus (202) and the stomach (201). The lining member (204) lines part of the inner surface of the oesophagus (202) for delivery of a therapeutic agent to the oesophagus (202).

Abstract: A medical treatment device (200), for treating reflux from a stomach (201) to an oesophagus (202) and for delivering a therapeutic agent to an inner surface of the oesophagus (202), comprises a valve member (203), a lining member (204), and a support member (205). The valve member (203) is movable between a closed configuration and an open configuration, in which the valve member (203) facilitates passage of material between the oesophagus (202) and the stomach (201). The valve member (203) is biased towards the closed configuration and gradually moves over a period of 4 to 10 secs from the open configuration to the closed configuration. The support member (205) supports the device (200) relative to the oesophagus (202) and the stomach (201). The lining member (204) lines part of the inner surface of the oesophagus (202) for delivery of a therapeutic agent to the oesophagus (202).

Abstract: A medical treatment device (200), for treating reflux from a stomach (201) to an oesophagus (202) and for delivering a therapeutic agent to an inner surface of the oesophagus (202), comprises a valve member (203), a lining member (204), and a support member (205). The valve member (203) is movable between a closed configuration and an open configuration, in which the valve member (203) facilitates passage of material between the oesophagus (202) and the stomach (201). The valve member (203) is biased towards the closed configuration and gradually moves over a period of 4 to 10 secs from the open configuration to the closed configuration. The support member (205) supports the device (200) relative to the oesophagus (202) and the stomach (201). The lining member (204) lines part of the inner surface of the oesophagus (202) for delivery of a therapeutic agent to the oesophagus (202).

Abstract: Disclosed is a method for providing secure access to multiple secure networks from a single workstation. The architecture can use multiple layers of protection to isolate applications running at different security levels. The first means of isolation is a virtual machine monitor that isolates multiple operating systems running within separate virtual machines on the host operating system. The second layer is the use of multiple user security contexts on the host operating system to isolate each virtual machine. The third level of protection is a highly secured and restricted host operating system where all unnecessary services are removed and user actions are restricted to just the virtual machine monitor using software restriction policies. Finally, the operating system and virtual machine monitor can be run from read-only media to prevent any changes by an attacker from persisting.

Abstract: Electronic signature functions, such as electronically signing an electronic record, verification of an electronic signature and issuance of keys, may be performed by a server or other central computer. For electronic signing, the server may access a key on a protected database and encryption programs to electronically sign an electronic record. For signature verification, the server may receive the electronic record and electronic signature, determine a key to decrypt the electronic signature, and then determine whether the electronic signature is valid. For issuance of keys, the server may receive a user request to generate keys, may generate the keys, and store the keys in a database which is accessible by the server, but which may not be accessible by the user.